AGC Biologics

AGC Biologics is owned by AGC Inc.

AGC Inc is one of the...

• Forbes Global 2000 (#1432);
• Nikkei 225;
• Topix.

AGC Inc is a company listed under the stock ticker 5201 (JP).

AGC Inc has a direct presence in 6 countries.

AGC Inc has 5 subsidiaries including AGC Biologics, AGC Biologics Denmark and AGC Glass Europe.

They are in:

• Materials50%
• Biotechnology33%
• Other17%

View the org chart displaying its 19 main executives

Most searched biographies at AGC Biologics

• Patricio Massera, Chief Executive Officer
• Jean-Baptiste Agnus, Chief Business Officer
• Paul Tsang, Executive Vice President, US Region

Popular executive movements at AGC Inc

• Nobuyuki Suzuki who is Executive Officer, General Manager of Electronic Materials General and Electronics Company, will be promoted to Senior Executive Officer, President of Electronics Company on Mar. 28, 2024  (posted on December 13 2023).
• Masao Nemoto who is Executive Vice President and President of Chemicals Company, will become Executive Vice President, Assistant Chief Executive Officer on Jan. 1, 2024  (posted on December 13 2023).
• Tadashi Murano who is Executive Officer, General Manager of Strategy, Planning and Corporate Planning General, will be promoted to Senior Executive Officer, President of Life Science Company on Mar. 28, 2024  (posted on December 13 2023).

Click here to view some more movements at AGC Inc

Create your alert
to follow the executive moves at AGC Biologics.

AGC Inc has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by AGC Biologics

• Contact Us | AGC Biologics
• Contact Us | AGC Biologics
• Contact Us | AGC Biologics
• AGC Biologics Appoints Dr. Christoph Winterhalter as CBO
• Contact Us | AGC Biologics
• AGC Biologics to Manufacture First-ever FDA Approved Gene Therapy
• Contact Us | AGC Biologics
• Contact Us | AGC Biologics
• Contact Us | AGC Biologics
• Contact Us | AGC Biologics
• View more press releases Close

Social media about AGC Biologics

• AGC Biologics on Wikipedia, Google News & Yahoo Finance
• AGC Biologics on LinkedIn, Twitter & YouTube

Contact by email its executives including Patricio Massera

Call AGC Biologics at +1 425...

View the org chart

Register to receive your alert

Report an error